Article info

Download PDFPDF

Response to: ‘Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al’ by Regueiro and Gonzalez
Free

Authors

  • Jianping Guo Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China PubMed articlesGoogle scholar articles
  • Tao Zhang Institute of Precision Health Research, Beijing genomics institute (BGI)-Shenzhen, Shenzhen, China Institute of Precision Health Research, China National GeneBank-Shenzhen, BGI-Shenzhen, Shenzhen, China PubMed articlesGoogle scholar articles
  • Xiaowei Li Institute of Precision Health Research, China National GeneBank-Shenzhen, BGI-Shenzhen, Shenzhen, China Technology Service Center, Beijing genomics institute (BGI)-shenzhen, shenzhen, China PubMed articlesGoogle scholar articles
  • Hongzhi Cao Division of Immunology, Shenzhen Digital Life Institute, Shenzhen, China Division of Artificial Intelligence and Bioinformatics, iCarbonX, ShenZhen, China Division of Birth Cohort Study, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhanguo Li Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jianping Guo, Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China; jianping.guo{at}bjmu.edu.cn
View Full Text

Citation

Guo J, Zhang T, Li X, et al
Response to: ‘Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al’ by Regueiro and Gonzalez

Publication history

  • Received February 25, 2020
  • Revised April 22, 2020
  • Accepted April 22, 2020
  • First published May 5, 2020.
Online issue publication 
February 14, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.